Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
APA | Ann: APA NTA 02-09-2025 $2.86485 | 07:57 | 0 | 21 | |||
|
|||||||
APA | Ann: APA NTA 01-09-2025 $2.86693 | 02/09/25 | 0 | 33 | |||
|
|||||||
APA | Ann: APA NTA 29-08-2025 $2.90658 | 01/09/25 | 0 | 20 | |||
|
|||||||
APA | Ann: APA NTA 28-08-2025 $2.90541 | 29/08/25 | 0 | 28 | |||
|
|||||||
APA | Ann: APA NTA 27-08-2025 $2.90067 | 28/08/25 | 0 | 27 | |||
|
|||||||
APA | Ann: APA NTA 26-08-2025 $2.89197 | 27/08/25 | 0 | 43 | |||
|
|||||||
APA | Ann: APA NTA 25-08-2025 $2.92622 | 26/08/25 | 0 | 61 | |||
|
|||||||
APA | Ann: APA NTA 22-08-2025 $2.89758 | 25/08/25 | 0 | 48 | |||
|
See All Discussions